Syneos Health to Participate in Fireside Chat at the 2022 Evercore ISI HealthCONx Conference
Syneos Health (Nasdaq:SYNH) announced that CEO Michelle Keefe will participate in a fireside chat at the 2022 Evercore ISI HealthCONx Conference on December 1, 2022, at 7:00 a.m. ET. The company will not hold investor meetings during this event. A live webcast will be available on the company's Investor Relations website, along with an archived replay link.
As a fully integrated biopharmaceutical solutions organization, Syneos Health accelerates customer success by strategically integrating clinical development, medical affairs, and commercial capabilities.
- None.
- None.
MORRISVILLE, N.C., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Michelle Keefe is scheduled to participate in a fireside chat at the 2022 Evercore ISI HealthCONx Conference on December 1, 2022, at 7:00 a.m. ET. The Company will not be hosting investor meetings.
A live webcast of the event, along with a link to the archived replay will be available on the Company’s Investor Relations website at investor.syneoshealth.com.
About Syneos Health
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically integrating clinical development, medical affairs and commercial capabilities to address modern market realities.
We bring together a talented team of professionals, across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.
Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.
To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
| Investor Relations Contact: | Press/Media Contact: |
| Ronnie Speight | Gary Gatyas |
| Senior Vice President, Investor Relations | Executive Director, External Communications |
| +1 919 745 2745 | +1 908 763 3428 |
| Investor.Relations@syneoshealth.com | gary.gatyas@syneoshealth.com |
FAQ
When is the Syneos Health fireside chat scheduled?
Who will represent Syneos Health at the Evercore ISI HealthCONx Conference?
Where can I watch the Syneos Health fireside chat?
Will Syneos Health hold investor meetings at the conference?
What is Syneos Health's stock symbol?
